Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

3rd In Vivo Cell Engineering and Gene Editing Summit

Evvnt Promotion / evvnt
-
09.07.2024 - 11.07.2024  The Colonnade Hotel, 120 Huntington Avenue, 02116 Boston, Massachusetts, USA
Time: 8:00 AM - 4:10 PM
 
Temi della conferenza
Welcome to the 3rd In Vivo Cell Engineering and Gene Editing Summit!

As promising pre-clinical and proof of concept results continue to emerge, the pivotal shift from the 'dream' of in vivo cell engineering and gene editing is rapidly becoming a reality as numerous companies push towards the clinic.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
URL:
Brochure: https://go.evvnt.com/2291382-3?pid=4832

Speakers: Adrian Bot, Chief Scientific Officer, Capstan Therapeutics, Cecile Bauche, Chief Scientific Officer, Alaya.bio, Colin Exline, Head of Gene Editing, Primera Therapeutics, and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/2291382-2?pid=4832
Ms. Kelly Cassidy
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 2599.00 - USD 5097.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Österreichische Akademie der ÄrztenewTreeAMREF - African Medical and Research FoundationSwiss Tropical and Public Health InstituteCenter of ExcellenceCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioHilfswerk AustriaÄrzte der Welt